ReviewAmerican journal of preventive cardiology2022

Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop.

Ann Marie Navar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.